- Trials with a EudraCT protocol (292)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (61)
292 result(s) found for: Granulocyte.
Displaying page 1 of 15.
EudraCT Number: 2006-000514-21 | Sponsor Protocol Number: AG-PH3 | Start Date*: 2007-01-02 |
Sponsor Name:CIS bio International | ||
Full Title: Multicenter, randomized, open-label, clinical study on the agreement of Scintimun® Granulocyte and labeled 99mTc-White Blood Cells in diagnosing infection/inflammation by immunoscintigraphy in peri... | ||
Medical condition: Patients with suspected or documented osteomyelitis in the peripheral skeleton including patients with loosening of joint prosthesis or diabetic foot. At least one of following signs or symptoms is... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) HU (Completed) DE (Completed) CZ (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-010700-28 | Sponsor Protocol Number: UniKoeln-478 | Start Date*: 2012-03-21 | |||||||||||
Sponsor Name:University of Cologne | |||||||||||||
Full Title: GRANITE-1 - Granulocyte-transfusions for patients with febrile neutropenia | |||||||||||||
Medical condition: Febrile neutropenia due to chemotherapy for the following diseases: C92.0- - Acute myeloid leukemia C91.0- - Acute lymphoblastic leukemia C92.1- - Chronic myeloid leukemia C91.1- - Chronic lymphobl... | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-003537-25 | Sponsor Protocol Number: 04032008 | Start Date*: 2008-08-28 |
Sponsor Name:University Medical Center Groningen | ||
Full Title: Can the steady-state hematopoiesis be improved post-ASCT by infusion of the autologous stem cell transplant directly in the bone marrow compartment. | ||
Medical condition: Study population - patient age 18-65 years - eligible for an ASCT for lymphoma or MM - at least ≥ 10 x 106 CD34+ cells/kg have been collected during the previous performed leucofereses procedure | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2006-004674-27 | Sponsor Protocol Number: 14076 | Start Date*: 2007-02-14 | |||||||||||
Sponsor Name:Dutch Kidney Foundation | |||||||||||||
Full Title: Effect of GM-CSF on development of antigen-specific T cell responses following hepatitis B vaccination | |||||||||||||
Medical condition: Haemodialysis patients are susceptible for infections due to a continuous mildly activated immune system. About 40% of the haemodialysis patients does not respond to the standard HBV vaccination pr... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-005349-39 | Sponsor Protocol Number: XM22-02-INT | Start Date*: 2008-04-09 |
Sponsor Name:BioGeneriX AG | ||
Full Title: Dose-finding of a fixed dose XM22 in patients with breast cancer receiving 4 cycles of chemotherapy versus 6 mg Neulasta® | ||
Medical condition: Neutropenia in patients with high risk stage II, stage III or stage IV breast cancer receiving cancer chemotherapy. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Completed) DE (Completed) HU (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2013-001639-38 | Sponsor Protocol Number: MDS/2013 | Start Date*: 2016-12-06 |
Sponsor Name:1st Dep. of Medicine, General University Hospital (VFN) in Prague | ||
Full Title: Contribution to verify the effectiveness of adding granulocyte stimulating factor (G-CSF) to therapy 5 - Azacitidine patients with the high risk Myelodysplastic syndrome. | ||
Medical condition: Patients with the diagnosis:HR-MDS, AML less than 30% myeloblasts and CMML II, who will be treated with AZA or AZA + G-CSF. | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: CZ (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-004211-30 | Sponsor Protocol Number: 2005-23 | Start Date*: 2005-10-17 |
Sponsor Name:The Norwegian Radium Hospital | ||
Full Title: Penicillin G and an aminoglycoside versus meropenem as initial empiric antibiotic therapy in lymphoma and leukemia patients with febrile neutropenia | ||
Medical condition: Lymphoma and leukemia patients with febrile neutropenia | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-002228-28 | Sponsor Protocol Number: STEMALS-II | Start Date*: 2014-09-01 |
Sponsor Name:Università degli Studi di Torino e Azienda Ospedaliera Città della Salute e della Scienza di Torino | ||
Full Title: A double blind, placebo controlled, parallel groups, multicenter study on filgrastim in amyotrophic lateral sclerosis | ||
Medical condition: Amyotrophic lateral sclerosis (ALS) is a severe progressive neurological disorder characterized by a selective degeneration of spinal, bulbar, and cortical motor neurons. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2007-006301-24 | Sponsor Protocol Number: 06/143 | Start Date*: 2008-02-21 | |||||||||||
Sponsor Name:University College London, Joint Research Office | |||||||||||||
Full Title: MULTI CENTRE CONTROLLED STUDY ON THE IMPACT OF STEM CELL DONATION EITHER AFTER MOBILISATION WITH GRANULOCYTE COLONY STIMULATING FACTOR OR BONE MARROW HARVEST ON UNRELATED BONE MARROW DONORS | |||||||||||||
Medical condition: Study on the impact of stem cell donation either after mobilisation with granulocyte colony stimulating factor (GCSF) or bone marrow harvest on unrelated donors. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-003581-25 | Sponsor Protocol Number: APA-III | Start Date*: 2015-05-26 |
Sponsor Name:University Hospital Tuebingen | ||
Full Title: Anti-inflammatory pulmonal therapy of CF-patients with Amitriptyline and Placebo - Randomised, double-blind, placebo-controlled cohort trial | ||
Medical condition: Amitriptyline reduces ceramide concentrations in bronchial epithelial cells and reduces cell death and reduces the deposition of DNA on the respiratory epithelium. This reduction promotes the elimi... | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2020-001654-21 | Sponsor Protocol Number: KKS-279 | Start Date*: 2020-09-16 | |||||||||||
Sponsor Name:Justus-Liebig-University Gießen | |||||||||||||
Full Title: Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Inhalation to prevent ARDS in COVID-19 pneumonia | |||||||||||||
Medical condition: COVID-19 pneumonia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-005256-97 | Sponsor Protocol Number: SGI-110-06 | Start Date*: 2017-06-19 | |||||||||||
Sponsor Name:Astex Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase 3, Multicenter, Randomized, Open-Label Study of Guadecitabine (SGI-110) versus Treatment Choice in Adults with Previously Treated Acute Myeloid Leukemia | |||||||||||||
Medical condition: Acute Myeloid Leukemia (AML) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) BE (Completed) HU (Completed) ES (Completed) GB (Completed) FR (Completed) PL (Completed) SE (Completed) DK (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-005772-16 | Sponsor Protocol Number: HEH-SF-01 | Start Date*: 2016-06-22 | ||||||||||||||||
Sponsor Name:Department of Surgery, Herlev Hospital | ||||||||||||||||||
Full Title: The safety and pharmacokinetics of intraperitoneal administration of granulocyte-macrophage colony-stimulating factor, fosfomycin, and metronidazole in patients undergoing appendectomy for uncompli... | ||||||||||||||||||
Medical condition: We intend to investigate the safety of treating secondary infectious peritonitis due to uncomplicated appendicitis with intraperitoneally administered fosfomycin, metronidazole and GM-CSF. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-005034-36 | Sponsor Protocol Number: KWI-300-104 | Start Date*: 2008-07-15 | |||||||||||
Sponsor Name:Apotex Inc. | |||||||||||||
Full Title: A non comparative, multicentre, repeat dose safety in use study of Neukine® (Filgrastim) in patients receiving chemotherapy known to induce neutropenia | |||||||||||||
Medical condition: Febrile neutropenia in breast cancer patients undergoing TAC chemotherapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: HU (Completed) AT (Completed) PL (Completed) BG (Completed) GR (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-000878-30 | Sponsor Protocol Number: 209564 | Start Date*: 2020-02-13 | |||||||||||
Sponsor Name:GlaxoSmithKline Research & Development Limited | |||||||||||||
Full Title: A multi-centre long-term extension study to assess the safety and efficacy of GSK3196165 in the treatment of rheumatoid arthritis. | |||||||||||||
Medical condition: Rheumatoid Arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LT (Ongoing) GB (GB - no longer in EU/EEA) CZ (Prematurely Ended) HU (Prematurely Ended) EE (Completed) DE (Prematurely Ended) LV (Completed) BG (Prematurely Ended) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-002195-10 | Sponsor Protocol Number: HO89 | Start Date*: 2009-05-06 | |||||||||||
Sponsor Name:HOVON Foundation | |||||||||||||
Full Title: A Phase II randomized multicenter study to assess the efficacy of lenalidomide with or without erythropoietin and granulocyte-colony stimulating factor in patients with low and intermediate-1 risk ... | |||||||||||||
Medical condition: myelodysplastic syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-004545-18 | Sponsor Protocol Number: NA | Start Date*: 2005-04-26 |
Sponsor Name:CHU Sart Tilman | ||
Full Title: Cell therapy for cardiac repair through mobilization of hematopoietic stem cells and endothelial progenitors in patients with chronic ischemic cardiomyopathy. | ||
Medical condition: Chronic ischemic cardiac disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-004849-26 | Sponsor Protocol Number: Parachute04 | Start Date*: 2015-02-05 | ||||||||||||||||
Sponsor Name:UMC Utrecht | ||||||||||||||||||
Full Title: PARACHUTE-trial Prospective Analysis of an individualized dosing Regimen of ATG (Thymoglobulin) in Children Undergoing HCT: redUcing Toxicity and improving Efficacy – a single arm phase II study | ||||||||||||||||||
Medical condition: Leukemia and immunedeficiency syndromes | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-003683-54 | Sponsor Protocol Number: OSHO #76 | Start Date*: 2008-06-18 |
Sponsor Name:GMIHO Gesellschaft für medizinische Innovation/Hämatologie und Onkologie mbH | ||
Full Title: Prospektive, offene, randomisierte, multizentrische Studie zur Effektivität von Palifermin in der Prophylaxe der Mukositis nach allogener Stammzelltransplantation mit myeloablativer Granzkörperbest... | ||
Medical condition: Patients suffering from leukemia (acute or chronic), receiving allogenic blood stem cell transplantation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-004981-42 | Sponsor Protocol Number: GCTSK001 | Start Date*: 2008-01-17 |
Sponsor Name:Narodny onkologicky ustav | ||
Full Title: Phase II study of sunitinib malate (SUTENT®) in relapsed germ cell tumors in males. | ||
Medical condition: germ cell tumor | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: SK (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.